NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas

Oncogene

Volumn 18, Issue 13, 1999, Pages 2231-2239

  Leone, Paola E ^a,e   Bello, M Josefa ^a   De Campos, Jose M ^b   Vaquero, Jesus ^c   Sarasa, Jose L ^d   Pestaña, Angel ^a   Rey, Juan A ^a  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^b HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^d Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^e PONTIFICIA UNIVERSIDAD CATÓLICA DEL ECUADOR   (Ecuador)

Author keywords

1p and 14q deletion mapping; Allelic losses; Meningiomas; NF2; Tumor progression

Indexed keywords

ARTICLE; CHROMOSOME 14Q; CHROMOSOME 1P; CHROMOSOME 22Q; EXON; GENE INACTIVATION; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENINGIOMA; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR GROWTH;

EID: 0033119495     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202531     Document Type: Article

References (54)

1. Al Saadi A, Latimer F, Madercic M and Robbins T. (1987). Cancer Genet. Cytogenet., 26, 127-141.
2. Bandera CA, Hiroyuki T, Behbakht K, Liu PC, LiVolsi VA, Benjamin I, Morgan MA, King SA, Rubin SC and Boyd J. (1997). Cancer Res., 57, 513-515.
3. Battersby RDE, Ironside JW and Maltby EL. (1986). J. Neurol. Neurosurg. Psychiatry, 49, 362-368.
4. Bello MJ, de Campos JM, Kusak ME, Vaquero J, Sarasa JL, Pestaña A and Rey JA. (1994). Genes Chrom. Cancer, 9, 296-298.
5. Bello MJ, Leone PE, Vaquero J, de Campos JM, Kusak ME, Sarasa JL, Pestana A and Rey JA. (1995). Int. J. Cancer, 64, 207-21 0.
6. Bender B, Wiestler OD and von Deimling AA. (1994). Biotechniques, 16, 204-206.
7. Biėche I, Champème M-H and Lidereau RA. (1994). Cancer Res., 54, 4274-4276.
8. Butti G, Assietti R, Casalone R and Paoletti P. (1989). Surg. Neurol., 31, 255-260.
9. Casalone R, Simi P, Granata P, Minelli E, Giudici A, Butti G and Solero CL. (1990). Cancer Genet. Cytogenet., 45, 237-244.
10. Casartelli C, Rogatto SR and Barbieri Neto J. (1989). Cancer Genet. Cytogenet., 40, 33-45.
11. Chang WY-H, Cairns P, Schoenberg MP, Polascik TJ and Sidransky D. (1995). Cancer Res., 55, 3246-3249.
12. De Vitis LR, Tedde A, Vitelli F, Ammannati F, Mennonna P, Bigozzi U, Montali E and Papi L. (1996). Hum. Genet., 97, 632-637.
13. Domenicucci M, Santoro A, D'Osvaldo DH, Delfini R, Cantore GP and Guidetti BJ. (1989). Neurosurg., 70, 41-44.
14. Fearon ER and Vogelstein B. (1990). Cell, 61, 759-767.
15. Feinberg D and Vogelstein B. (1984). Anal. Biochem., 137, 266-267.
16. Fujino T, Risinger JI, Collins NK, Liu F-S, Nishii H, Takashashi H, Wetsphal EM, Barrett JC, Sasaki H, Kohler MF, Berchuck A and Boyd J. (1994). Cancer Res., 54, 4294-4298.
17. Harada T, Irving RM, Xuereb JH, Barton DE, Hardy DG, Moffat DA and Maher ER. (1996). J. Neurosurg., 84, 847-851.
18. Jost CA, Marin MC and Kaelin WG. (1997). Nature, 389, 191-194.
19. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan J-C, Valent A, Minty A, Chalon P, Lelias J-M, Dumont X, Ferrara P, McKeon F and Caput D. (1997). Cell, 90, 809-819.
20. Kleihues P, Burger PC and Scheitauer BW. (1993). Brain Pathol., 3, 255-268.
21. Kovacs G. (1993). Histopathol. (Oxf.), 22, 1-8.
22. Kraus JA, Koopmann J, Kaskel P, Maintz D, Brandner S, Schramm J, Louis DN, Wiestler OD and von Deimling A. (1995). J. Neuropathol. Exp. Neurol., 54, 91-95.
23. Lekanne-Deprez RH, Blanchi AB, Groen NA, Seizinger BR, Hagemeijer A, van Drunen E, Bootsma D, Koper JW, Avezaat CJJ, Kley N and Zwarthoff EC. (1994). Am. J. Hum. Genet., 54, 1022-1029.
24. Lekanne-Deprez RH, Riegman PH, van Drunen E, Warringa UL, Groen NA, Stefanko SZ, Koper JW, Avezaat CJJ, Mulder PGH, Zwarthoff EC and Hagemeijer A. (1995). J. Neuropathol. Exp. Neurol., 54, 224-235.
25. Lekanne-Deprez RH, Riegman PH, Groen NA, Warringa UL, van Biezen NA, Molijn AC, Bootsma D, de Jong PJ, Menon AG, Kley NA, Seizinger BR and Zwarthoff EC. (1995). Oncogene, 10, 1521-1528.
26. Lindblom A, Ruttledge M, Collins VP, Nordenskjöld M and Dumanski JP. (1994). Int. J. Cancer, 56, 354-357.
27. Lopez-Gines C, Cerda-Nicolas M, Barcia-Salorio JL and Llombart-Bosch A. (1995). Cancer Genet. Cytogenet., 85, 113-117.
28. Maltby EL, Ironside JW and Battersby RDE. (1988). Cancer Genet. Cytogenet., 31, 199-210.
29. Martuza RL and Eldridge R. (1988). New Engl. J. Med., 318, 684-687.
30. Memon MY. (1980). Neurosurgery, 7, 262-264.
31. Menon AG, Rutter JL, von Sattel JP, Synder H, Murdoch C, Blumenfeld A, Martuza RL, von Deimling A, Gusella JF and Houseal TH. (1997). Oncogene, 14, 611-616.
32. Merel P, Hoang-Xuan K, Sanson M, Moreau-Aubry A, Bijlsma EK, Lazaro C, Moisan JP, Resche F, Nishisho I, Estivill X, Delatre JY, Poisson M, Theillet C, Hulsebos T, Delattre O and Thomas G. (1995). Genes Chrom. Cancer, 13, 211-216.
33. Mertens F, Johansson B, Höglund M and Mitelman F. (1997). Cancer Res., 57, 2765-2780.
34. Papi L, De Vitis LR, Vitelli K, Ammannati F, Mennonna P, Montali E and Bigozzi U. (1995). Hum. Genet., 95, 347-351.
35. Perry A, Jenkins RB, Dahl RJ, Moertel CA and Scheithauer BW. (1996). Cancer, 77, 2567-2573.
36. Peyrard M, Fransson I, Xie Y-G, Huan F-Y, Ruttledge MH, Swahn S, Collins JE, Dunham I, Collins VP and Dumanski JP. (1994). Hum. Mol. Genet., 3, 1393-1399.
37. Poulsgard L, Ronne M and Schmidek HH. (1993). In: Molecular Genetics of Nervous System Tumors. Levine AJ and Schmidek HH (eds). Wiley-Liss: New York. 249-254.
38. Rasio D, Murakumo Y, Robbins D, Roth T, Silver A, Negrini M, Schmidt C, Burczak J, Fishel R and Croce CM. (1997). Cancer Res., 57, 2378-2383.
39. Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W and Collins VP. (1994). Am. J. Pathol., 145, 1175-1190.
40. Rempel SA, Schwechheimer K, Davis RL, Cavence WK and Rosemblum ML. (1993). Cancer Res., 53, 2386-2392.
41. Rey JA, Bello MJ, de Campos JM, Kusak ME and Moreno S. (1988). Cancer Genet. Cytogenet., 33, 275-290.
42. Rey JA, Bello MJ, Jimenez-Lara AM, Vaquero J, Kusak ME, de Campos JM, Sarasa JL and Pestaña A. (1992). Int. J. Cancer, 51, 703-706.
43. Rigby PW, Dieckmann M, Rhodes C and Berg P. (1977). J. Mol. Biol., 113, 237-251.
44. Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Murineau C, Hoang-Xuan K, Demczuk S, Desmaze C, Plougastel B, Pulst SM, Lenoir G, Bijlsma E, Fashold R, Dumanski J, de Jong P, Parry D, Eldrige R, Aurias A, Delattre O and Thomas G. (1993). Nature, 363, 515-521.
45. Ruttledge MH, Sarrazin J, Rangaratman S, Phelan CM, Twist E, Merel P, Delattre O, Thomas G, Nordenskjöld, Collins VP, Dumanski JP and Rouleau GA. (1994). Nature Genet., 6, 180-184.
46. S chneider BF, Shashi V, von Kap-Herr C and Golden WL. (1995). Cancer Genet. Cytogenet., 85, 101-104.
47. Schwab M, Praml C and Amler LC. (1996). Genes Chrom. Cancer, 16, 211-229.
48. Simon M, von Deimling A, Larson JL, Wellenreuther R, Kaskel P, Waha A, Warnick RE, Tew JM and Menon AG. (1995). Cancer Res., 55, 4696-4701.
49. Takayama H, Suzuki T, Mugishima H, Fujisawa T, Ookuni M, Schwab M, Gehring M, Nakamura Y, Sugimura T, Terada M and Yokota J. (1992). Oncogene, 7, 1185-1189.
50. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K, Haase VH, Ambrose CM, Munroe D, Bove C, Haines JL, Martuza RL, MacDonald ME, Seizinger BR, Short MP, Buckler AJ and Gusella JF. (1993). Cell, 72, 791-800.
51. Vagner-Capodano AM, Grisoli F, Gambarelli D, Sedan R, Pellet W and De Victor B. (1993). Neurosurgery, 32, 892-900.
52. Wellenreuther R, Kraus JA, Lenartz D, Menon AG, Schramm J, Louis DN, Ramesh V, Gusella JF, Wiestler OD and von Deimling A. (1995). Am. J. Pathol., 146, 827-832.
53. Young J, Leggett B, Ward M, Thomas L, Buttenshaw R, Scarle J and Chenevix-Trench G. (1993). Oncogene, 8, 671-675.
54. Zang KD. (1982). Cancer Genet. Cytogenet., 6, 249-274.